HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nathan Ihle Selected Research

4- dodecyl- N- (1,3,4- thiadiazol- 2- yl)benzenesulfonamide

3/2010Molecular pharmacology and antitumor activity of PHT-427, a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitor.
6/2009In vitro and in vivo activity of novel small-molecule inhibitors targeting the pleckstrin homology domain of protein kinase B/AKT.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nathan Ihle Research Topics

Disease

4Neoplasms (Cancer)
03/2010 - 01/2004
2Breast Neoplasms (Breast Cancer)
03/2010 - 01/2004
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2010
1Weight Loss (Weight Reduction)
03/2010
1Pancreatic Neoplasms (Pancreatic Cancer)
06/2009
1Hemolysis
01/2004
1Colonic Neoplasms (Colon Cancer)
01/2004

Drug/Important Bio-Agent (IBA)

24- dodecyl- N- (1,3,4- thiadiazol- 2- yl)benzenesulfonamideIBA
03/2010 - 06/2009
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
03/2010 - 06/2009
1platelet protein P47 (pleckstrin)IBA
03/2010
1Erlotinib Hydrochloride (CP 358,774)FDA Link
03/2010
1Protein Kinases (Protein Kinase)IBA
03/2010
1Paclitaxel (Taxol)FDA LinkGeneric
03/2010
13-Phosphoinositide-Dependent Protein KinasesIBA
09/2008
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
09/2008
1Phospholipids (Phosphatides)FDA LinkGeneric
09/2008
1Insulin Receptor Substrate ProteinsIBA
09/2008
1Phosphatidylinositols (Phosphatidylinositol)IBA
09/2008
1Dihydrotachysterol (AT 10)IBA
01/2004
12-Hydroxypropyl-beta-cyclodextrinIBA
01/2004
11- ((1- O- octadecyl- 2- O- methylglycero)phospho)- 3- deoxy- myo- inositolIBA
01/2004
1WortmanninIBA
01/2004

Therapy/Procedure

1Intravenous Administration
01/2004